ilumin8bio Revenue

Pharmaceutical Manufacturing • Christchurch, Canterbury, New Zealand • 1-10 Employees

ilumin8bio revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at ilumin8bio

Shawn Melley

Chief Executive Officer

Company overview

Headquarters	Christchurch, Canterbury, New Zealand
NAICS	3254
Founded	2024
Employees	1-10

About ilumin8bio

ilumin8bio is a leader in precision cancer therapies, creating first-in-class solutions using next-generation antibody conjugation technologies to improve therapeutic efficacy while reducing toxicity. We specialize in advanced linker chemistry and solid-phase synthesis platforms for both Antibody-Drug Conjugates (ADCs) and Targeted Radionuclide Therapies (TRTs). Our proprietary solid-phase synthesis approach enables homogeneous drug-to-antibody ratios, multi-payload loading capabilities, and site-specific conjugation—addressing critical limitations in current cancer treatments. Our expertise in solid-phase synthesis creates simplified manufacturing processes that simultaneously increase yield, efficiency, quality, and safety while reducing costs. This breakthrough approach helps biotechnology and pharmaceutical companies overcome the conjugation bottlenecks that have limited the success of targeted cancer therapies. Through our innovative linker platforms, we're transforming how precision oncology treatments are designed, manufactured, and delivered to patients who need them most.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

ilumin8bio has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

ilumin8bio has never raised funding before.

Frequently asked questions

ilumin8bio is located in Christchurch, Canterbury, NZ.

ilumin8bio generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

ilumin8bio has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

ilumin8bio was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

ilumin8bio has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at ilumin8bio

Shawn Melley

Chief Executive Officer

4.8

40,000 users